Experimental orthotopic tracheal transplantation: The Stanford technique

Microsurgery

Volumn 27, Issue 3, 2007, Pages 187-189

  Schrepfer, Sonja ^a   Deuse, Tobias ^b   Hoyt, Grant ^a   Sheikh, Ahmad Y ^a   Hoffmann, Joerg ^a   Reichenspurner, Hermann ^b   Robbins, Robert C ^a   Pelletier, Marc P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AIRFLOW; AIRWAY OBSTRUCTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS OBLITERANS; CHRONIC GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; MUCOCILIARY CLEARANCE; NONHUMAN; ORTHOTOPIC TRACHEAL TRANSPLANTATION; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; RAT; SURGICAL TECHNIQUE;

ANIMALS; MODELS, ANIMAL; RATS; SUTURE TECHNIQUES; TRACHEA;

EID: 34247253093     PISSN: 07381085     EISSN: 10982752     Source Type: Journal    
DOI: 10.1002/micr.20329     Document Type: Article

References (10)

1. Hertz MI, Jessurun J, King MB, Savik SK, Murray JJ. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am J Pathol 1993;142:1945-1951.
2. Huang XH, Reichenspurner H, Shorthouse R, Morris RE. Heterotopic tracheal allograft transplantation: A new model to study the molecular events causing obliterative airway disease (OAD) in rats. J Heart Lung Transplant 1995;14 (Suppl):49 (abstract).
3. Koskinen PK, Kallio EA, Krebs R, Lemstrom KB. A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts. Am J Respir Crit Care Med 1997;155:303-312.
4. Morris RE, Huang X, Gregory CR, Billingham ME, Rowan R, Shorthouse R, Berry GJ. Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis. Transplant Proc 1995;27:2068-2069.
5. Reichenspurner H, Soni V, Nitschke M, Berry GJ, Brazelton TR, Shorthouse R, Reitz BA, Berry GJ, Morris RE. Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents. Transplantation 1997;64:373-383.
6. Harjula A, Baldwin JC, Tazelaar HD, Jamieson SW, Reitz BA, Shumway NE. Minimal lung pathology in long-term primate survivors of heart-lung transplantation. Transplantation 1987;44:852-854.
7. Randone B, Sterpetti AV, Stipa F, Proietti P, Aromatario C, Guglielmi MB, Palestini M, Santoro-D'Angelo L, Cavallaro A, Cucina A. Growth factors and myointimal hyperplasia in experimental aortic allografts. Eur J Vasc Endovasc Surg 1997;13:66-71.
8. Saenz NC, Hendren RB, Schoof DD, Folkman J. Reduction of smooth muscle hyperplasia in vein grafts in athymic rats. Lab Invest 1991;65:15-22.
9. Deuse T, Schrepfer S, Koch-Nolte F, Haddad M, Schafer H, Detter C, Reichenspurner H. Sirolimus and FK778: A comparison of two anti-proliferative immunosuppressants for prevention of experimental obliterative airway disease. Transpl Int 2006;19:310-318.
10. Deuse T, Schrepfer S, Koch-Nolte F, Haddad M, Schwedhelm E, Boger R, Schafer H, Detter C, Reichenspurner H. FK778 and tacrolimus prevent the development of obliterative airway disease after heterotopic rat tracheal transplantation. J Heart Lung Transplant 2005;24:1844-1854.